Admed s.r.o.
- Address
- Tr. Csl. Legii 2118/6, 370 06 České Budějovice, Czechia
Digestive System Diseases
At Admed s.r.o. in Czechia, this research area focuses on digestive system diseases and the impact of antibiotic therapy on the gut microbiota. The studies are designed to better understand how supportive treatments may help preserve intestinal balance during antibiotic use.
- Evaluating the effect of Saccharomyces boulardii CNCM I-745 alongside antibiotic treatment
- Studying changes in gut microbiota during therapy for erythema migrans
- Exploring ways to support digestive health during antibiotic therapy
This line of research aims to improve comfort and treatment support for patients receiving antibiotics, with a focus on maintaining healthier digestive function.
Virus Diseases
The site also conducts research in virus diseases, with a strong emphasis on influenza in older adults. These trials evaluate whether vaccination can offer effective protection against seasonal flu while remaining safe and well tolerated.
- Assessing prevention of influenza A and B in adults aged 65 years and older
- Comparing a flu vaccine option with a non-adjuvanted influenza vaccine
- Measuring the ability of vaccination to reduce RT-PCR-confirmed influenza
Overall, this research supports efforts to improve influenza prevention and strengthen protection for an age group that is especially vulnerable to complications from viral infection.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Admed s.r.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of MF59-Adjuvanted Influenza Vaccine Versus Non-Adjuvanted Vaccine in Adults Aged 65 and Older | Seqirus UK Limited | Phase III | Not Recruiting | Oct 2023 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| A/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227) | 1 | Unknown | 2023-10-20 | 2023-10-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.